Alico, Inc. (NASDAQ:ALCO – Get Free Report) was the target of a significant increase in short interest in the month of January. As of January 15th, there was short interest totalling 239,300 shares, an increase of 7.9% from the December 31st total of 221,700 shares. Based on an average daily volume of 52,400 shares, the days-to-cover ratio is presently 4.6 days. Approximately 4.5% of the company’s stock are sold short.
Alico Stock Down 1.9 %
NASDAQ:ALCO traded down $0.60 during mid-day trading on Monday, hitting $30.29. The stock had a trading volume of 17,076 shares, compared to its average volume of 96,671. The company has a current ratio of 3.81, a quick ratio of 0.99 and a debt-to-equity ratio of 0.35. Alico has a twelve month low of $24.14 and a twelve month high of $34.08. The stock has a 50-day simple moving average of $28.18 and a two-hundred day simple moving average of $27.58. The company has a market capitalization of $231.42 million, a PE ratio of 33.09 and a beta of 0.81.
Alico Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, January 10th. Shareholders of record on Friday, December 27th were issued a dividend of $0.05 per share. The ex-dividend date was Friday, December 27th. This represents a $0.20 dividend on an annualized basis and a yield of 0.66%. Alico’s payout ratio is currently 21.74%.
Hedge Funds Weigh In On Alico
About Alico
Alico, Inc, together with its subsidiaries, operates as an agribusiness and land management company in the United States. The company operates in two segments, Alico Citrus, and Land Management and Other Operations. The Alico Citrus segment engages in planting, owning, cultivating, and/or managing citrus groves to produce fruit for sale to fresh and processed citrus markets, including activities related to the purchase and resale of fruit and value-added services, which include contracting for the harvesting, marketing, and hauling of citrus.
Further Reading
- Five stocks we like better than Alico
- What Investors Need to Know About Upcoming IPOs
- Teva Pharma: Why This Generic Drug Giant Is a Smart Buy Now
- What Is WallStreetBets and What Stocks Are They Targeting?
- Big Dividend Hikes: 4 Large-Cap Stocks Increasing Payouts
- Technology Stocks Explained: Here’s What to Know About Tech
- Procter & Gamble: A Consumer Staples Titan Built to Win
Receive News & Ratings for Alico Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alico and related companies with MarketBeat.com's FREE daily email newsletter.